Item 5.07 Submission of Matters to a Vote of Security Holders.

As previously reported, on December 7, 2022, Xenetic Biosciences, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"), which was partially adjourned to December 21, 2022 solely with respect to the voting on Proposal Four. The Company reconvened the Annual Meeting on December 21, 2022, and the stockholders of the Company voted on Proposal Four as described below.

Proposal Four: The Company's stockholders voted upon and approved and adopted an amendment to the Company's Articles of Incorporation to increase the authorized number of shares of the Company's common stock from 50,000,000 shares to 100,000,000 shares. The votes on this proposal were as follows:





   For       Against    Abstained   Broker Non-Votes
7,204,486   1,131,034    110,245           -

No other matters were considered or voted upon at the Annual Meeting.











  2

© Edgar Online, source Glimpses